结合分子与组织学终点评估意义未明的不典型甲状腺结节的癌症风险
该研究纳入279个初次细针穿刺细胞学分类为意义未明的不典型(AUS)且接受Afirma基因表达分类器(GEC)检测的甲状腺结节,按AUS亚型分层,结合GEC结果与组织病理诊断计算NIFTP/癌症风险。
核心结论
- 将GEC良性且未切除的结节作为低风险终点纳入计算,可获得更准确的风险评估。
研究设计与样本
- 按AUS细胞学或架构学分类器分层,并将AUS-A进一步分为少细胞微滤泡型和混合但以微滤泡为主的细胞型。
临床怎么用
- 在AUS结节风险评估中可考虑结合GEC分子结果与组织学终点,以提高风险分层准确性。
- 对AUS-A亚型可进一步区分少细胞微滤泡型与混合/微滤泡为主细胞型以辅助管理决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thyroid nodules classified as atypia of uncertain significance (AUS) on fine-needle aspiration cytology are heterogeneous. Prior studies reported a higher risk of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)/cancer among AUS nodules that had cytologic (AUS-C) versus architectural (AUS-A) atypia; however, such studies were generally confined to resected cohorts, introducing bias into risk calculations. The authors hypothesized that combined histologic and molecular end points would permit clinically meaningful calculations of NIFTP/malignancy risk among AUS nodules. METHODS: The study consisted of 279 thyroid nodules classified as AUS on initial fine-needle aspiration and tested by the Afirma Gene Expression Classifier (GEC) between June 2013 and October 2017. Results of GEC testing and histopathologic diagnoses were stratified by AUS classifiers. The AUS-A category was further subclassified as 1) hypocellular microfollicular or 2) cellular with mixed but predominantly microfollicular architecture. NIFTP/cancer risk was calculated for each subgroup, with the inclusion of unresected nodules that had benign GEC results as low-risk end points comparable to histologically benign nodules. RESULTS: When only histologic end points were considered, there was no difference in NIFTP/cancer risk (25% vs 23%; P = .82). By using molecular and histologic end points, AUS cases with cytologic atypia trended toward higher NIFTP/cancer risk than AUS-A cases (14% vs 6%; P = .06). Furthermore, AUS-A cases showed a trend toward lower NIFTP/cancer risk for hypocellular microfollicular aspirates (3%) compared with cellular samples that had mixed/predominantly microfollicular architecture (13%; P = .18). CONCLUSIONS: The inclusion of unresected benign GEC nodules in risk-of-malignancy calculations provides more accurate results, which may be helpful for informing patient management as well as quality improvement in the cytopathology laboratory.
引用
- Onken AM, VanderLaan PA, Hennessey JV, et al. Combined molecular and histologic end points inform cancer risk estimates for thyroid nodules classified as atypia of undetermined significance. Cancer Cytopathol. 2021. PMID: 34314102. doi:10.1002/cncy.22489
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。